Pharmaceuticals / fine chemicals Roundup

pharmaceutical products

Pharmaceuticals / fine chemicals Roundup
Articles by

Emma438

European Fine Chemicals Group (EFCG; Brussels) says its board has decided to amend the U.S. Food and Drug Administration (FDA) submission of the legislative package, with EFCG designed to ratify the U.S. industry representatives, to U.S. law to provide a new generic drug user fees (GDUFA). GDUFA requires the FDA to make, significantly enhance the regulatory activities for the global generic pharmaceutical companies and generic drug use in the U.S. for the global generics industry provides the FDA with 9 million in royalties every year for five years. The main advantages of the drug companies to become more predictable times faster regulatory review, including dealing with the backlog of applications, and the parity of the tests between domestic and foreign locations of active pharmaceutical ingredients (API) and finished dosage form manufacturers.

LANXESS to expand the capacity of thionyl chloride in India

Lanxess says it will increase production capacity by 20% of its factory thionyl chloride Nagda, Madhya Pradesh state in India and the expansion will be completed in the second half of 2012. The project is a single-digit million euros will be invested Lanxess says. Thionyl chloride is a key intermediate to produce chemicals, pharmaceuticals fine, agchems and colors to use, Lanxess.

“Indian demand [for thionyl chloride] increased by 8% in recent years has grown and we expect continued steady growth in demand,” says Hubert Fink, interim director of Advanced Industrial unit at LANXESS business. Operations on the Nagda are part of an intermediate unit of Advanced Industrial business segment is part of Lanxess advanced intermediates, and the segment generated sales of approximately € 1.3 billion in 2010.

Albemarle to increase prices of generic APIs

Albemarle says it’s the world price generic active pharmaceutical ingredients (API) of 8% -12% according to amplify the specific product. Price increases take effect from October 15, 2011 take effect unless existing contracts state otherwise, says Albemarle. “Increase in price will ensure through a challenging economic environment, we were able to achieve the superior quality and state regulation and services are,” says Albemarle. Albemarle generic APIs are part of the company’s services Fine Chemicals (FCS) Unit Fine Chemicals Division of Global Business. FCS division manufactures bulk APIs and niche markets for prescription drugs on prescription, and offers custom manufacturing, R & D and other services for manufacturers of medicines, agricultural chemicals, and other special materials to high value markets.

BIOCON biological factory building in Malaysia

biotechnology company Biocon (Bangalore, India) says, she began constructing a biopharmaceutical manufacturing research and development facility in Bio-XCell, ecological biotechnology park was installed began Iskander Malaysia, in Johor, Malaysia. Biocon is approximately 1 million first phase of construction plant , which is expected to invest in 2014. The project will study the development and production of other biopharmaceuticals later.

This article was printed Guidechem http://www.guidechem. com

Cordex Pharma, Inc – Product Pipeline Review – Q4 2010

pharmaceutical products -. Click on image below for more information

pharmaceutical products

Cordex Pharma, Inc – Product Pipeline Review – Q4 2010 Global Direct Market Summary

Pharma report, “Cordex Pharma, Inc – Product Pipeline Review – Q4 2010″ provides data on the company focus on research and development. The report information about the current development pipeline, including updates on new features dormant discontinued projects.
This report was produced using data and information derived from Global Markets Direct Pro

Cordex Pharma, Inc – Product Pipeline Review – Q4 2010

Filed under: Pharma Products · Tags: chemicals, fine, Pharmaceuticals, Roundup